{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:42:46Z","timestamp":1790991766479,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030028"],"award-info":[{"award-number":["2023A1515030028"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030028"],"award-info":[{"award-number":["2023A1515030028"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818100806015"],"award-info":[{"award-number":["JCYJ20220818100806015"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818100806015"],"award-info":[{"award-number":["JCYJ20220818100806015"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02031-6","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T23:35:03Z","timestamp":1744846503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5441-5306","authenticated-orcid":false,"given":"Lawan","family":"Rabiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid I.","family":"Gidado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad A.","family":"Saliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza Kashaf","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-5262","authenticated-orcid":false,"given":"Guizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"8","key":"2031_CR1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s12276-020-0480-3","volume":"52","author":"S-Y Koo","year":"2020","unstructured":"Koo S-Y, Park E-J, Lee C-W. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Exp Mol Med. 2020;52(8):1209\u201319.","journal-title":"Exp Mol Med"},{"key":"2031_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-024-02157-0","author":"L Rabiu","year":"2024","unstructured":"Rabiu L, Zhang P, Afolabi LO, et al. Immunological dynamics in MASH: from landscape analysis to therapeutic intervention. J Gastroenterol. 2024. https:\/\/doi.org\/10.1007\/s00535-024-02157-0. PMID: 39400718.","journal-title":"J Gastroenterol."},{"issue":"7","key":"2031_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"key":"2031_CR4","doi-asserted-by":"publisher","unstructured":"FDA approves first MASH drug. Nat Biotechnol. 2024;42(4):540. https:\/\/doi.org\/10.1038\/s41587-024-02220-4.","DOI":"10.1038\/s41587-024-02220-4"},{"issue":"4","key":"2031_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"D Liver EAftSot","year":"2024","unstructured":"Liver EAftSot D, EAftSo O, EAftSo. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374\u2013444.","journal-title":"Obes Facts"},{"issue":"9","key":"2031_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.it.2013.04.005","volume":"34","author":"V Bieghs","year":"2013","unstructured":"Bieghs V, Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol. 2013;34(9):446\u201352. https:\/\/doi.org\/10.1016\/j.it.2013.04.005. Epub 20130511.","journal-title":"Trends Immunol"},{"issue":"3","key":"2031_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/hep.31832","volume":"74","author":"Y Liu","year":"2021","unstructured":"Liu Y, Song J, Yang J, et al. Tumor necrosis factor \u03b1\u2013Induced protein 8\u2013Like 2 alleviates nonalcoholic fatty liver disease through suppressing transforming growth factor Beta\u2013Activated kinase 1 activation. Hepatology. 2021;74(3):1300\u201318.","journal-title":"Hepatology"},{"issue":"3","key":"2031_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","volume":"133","author":"H Sun","year":"2008","unstructured":"Sun H, Gong S, Carmody RJ, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008;133(3):415\u201326.","journal-title":"Cell"},{"key":"2031_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00109-015-1288-9","volume":"93","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhu T, Liu W, et al. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia\/reperfusion injury. J Mol Med. 2015;93:1033\u201343.","journal-title":"J Mol Med"},{"key":"2031_CR10","doi-asserted-by":"publisher","first-page":"155690","DOI":"10.1016\/j.metabol.2023.155690","volume":"148","author":"Y Tao","year":"2023","unstructured":"Tao Y, Zhao J, Yin J, et al. Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis. Metabolism. 2023;148:155690. https:\/\/doi.org\/10.1016\/j.metabol.2023.155690. Epub 20230916.","journal-title":"Metabolism"},{"issue":"11","key":"2031_CR11","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/cbin.11443","volume":"44","author":"D Lu","year":"2020","unstructured":"Lu D, Yang Z, Xia Q, et al. ACADSB regulates ferroptosis and affects the migration, invasion, and proliferation of colorectal cancer cells. Cell Biol Int. 2020;44(11):2334\u201343.","journal-title":"Cell Biol Int"},{"key":"2031_CR12","doi-asserted-by":"publisher","first-page":"143939","DOI":"10.1016\/j.gene.2019.06.029","volume":"711","author":"S Yarahmadi","year":"2019","unstructured":"Yarahmadi S, Abdolvahabi Z, Hesari Z, et al. Inhibition of Sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene. 2019;711:143939.","journal-title":"Gene"},{"issue":"12","key":"2031_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","volume":"4","author":"S Gallage","year":"2022","unstructured":"Gallage S, Avila JEB, Ramadori P, et al. A researcher\u2019s guide to preclinical mouse NASH models. Nat Metabolism. 2022;4(12):1632\u201349.","journal-title":"Nat Metabolism"},{"issue":"12","key":"2031_CR14","doi-asserted-by":"publisher","first-page":"e0243911","DOI":"10.1371\/journal.pone.0243911","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Liu C, Zhao M, et al. The pharmacodynamic and differential gene expression analysis of PPAR \u0391\/\u03b4 agonist GFT505 in CDAHFD-induced NASH model. PLoS ONE. 2020;15(12):e0243911.","journal-title":"PLoS ONE"},{"issue":"3","key":"2031_CR15","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.xpro.2020.100222","volume":"1","author":"Y Jung","year":"2020","unstructured":"Jung Y, Zhao M, Svensson KJ. Isolation, culture, and functional analysis of hepatocytes from mice with fatty liver disease. STAR Protoc. 2020;1(3):100222. https:\/\/doi.org\/10.1016\/j.xpro.2020.100222. Epub 20201215.","journal-title":"STAR Protoc"},{"key":"2031_CR16","doi-asserted-by":"publisher","first-page":"112628","DOI":"10.1016\/j.jim.2019.06.019","volume":"474","author":"S Schaffer","year":"2019","unstructured":"Schaffer S, Maul-Pavicic A, Voll RE, et al. Optimized isolation of renal plasma cells for flow cytometric analysis. J Immunol Methods. 2019;474:112628. https:\/\/doi.org\/10.1016\/j.jim.2019.06.019. Epub 20190626.","journal-title":"J Immunol Methods"},{"issue":"2","key":"2031_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1556\/EuJMI.2.2012.2.3","volume":"2","author":"A Autengruber","year":"2012","unstructured":"Autengruber A, Gereke M, Hansen G, et al. Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. Eur J Microbiol Immunol (Bp). 2012;2(2):112\u201320. https:\/\/doi.org\/10.1556\/EuJMI.2.2012.2.3. Epub 20120613.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"11","key":"2031_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41419-021-04289-0","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang N, Ma C, et al. The overexpression of Tipe2 in CRC cells suppresses survival while endogenous Tipe2 accelerates AOM\/DSS induced-tumor initiation. Cell Death Dis. 2021;12(11):1001. https:\/\/doi.org\/10.1038\/s41419-021-04289-0.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2031_CR19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1136\/gutjnl-2019-319745","volume":"69","author":"J Vily-Petit","year":"2020","unstructured":"Vily-Petit J, Soty-Roca M, Silva M, et al. Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. Gut. 2020;69(12):2193\u2013202. https:\/\/doi.org\/10.1136\/gutjnl-2019-319745. Epub 20200323.","journal-title":"Gut"},{"issue":"6","key":"2031_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41575-020-0301-0","volume":"17","author":"I Dickson","year":"2020","unstructured":"Dickson I. Intestinal gluconeogenesis prevents hepatic steatosis. Nat Reviews Gastroenterol Hepatol. 2020;17(6):316. https:\/\/doi.org\/10.1038\/s41575-020-0301-0.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2031_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11050320","author":"M Yang","year":"2021","unstructured":"Yang M, Ma F, Guan M. Role of steroid hormones in the pathogenesis of nonalcoholic fatty liver disease. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11050320. PubMed PMID: 34067649; PubMed Central PMCID: PMC8156407.","journal-title":"Metabolites."},{"issue":"1","key":"2031_CR22","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1038\/s41598-023-34137-4","volume":"13","author":"X Jia","year":"2023","unstructured":"Jia X, Zhang X, Yan M, et al. Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury. Sci Rep. 2023;13(1):6897. https:\/\/doi.org\/10.1038\/s41598-023-34137-4.","journal-title":"Sci Rep"},{"issue":"1","key":"2031_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. https:\/\/doi.org\/10.1186\/s12944-017-0409-6. Epub 20170119.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2031_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2478\/rjim-2020-0029","volume":"59","author":"D Darmadi","year":"2021","unstructured":"Darmadi D, Ruslie RH. Association between serum Interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Rom J Intern Med. 2021;59(1):66\u201372. https:\/\/doi.org\/10.2478\/rjim-2020-0029. Epub 2020\/10\/16.","journal-title":"Rom J Intern Med"},{"issue":"1","key":"2031_CR25","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1038\/s41467-024-49633-y","volume":"15","author":"RH Friedline","year":"2024","unstructured":"Friedline RH, Noh HL, Suk S, et al. IFN\u03b3-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2024;15(1):5506. https:\/\/doi.org\/10.1038\/s41467-024-49633-y. Epub 2024\/07\/02.","journal-title":"Nat Commun"},{"issue":"19","key":"2031_CR26","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.3390\/jcm12196216","volume":"12","author":"W Eskridge","year":"2023","unstructured":"Eskridge W, Cryer DR, Schattenberg JM, et al. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective. J Clin Med. 2023;12(19):6216.","journal-title":"J Clin Med"},{"issue":"5","key":"2031_CR27","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/j.jhep.2023.10.036","volume":"80","author":"T Shao","year":"2024","unstructured":"Shao T, Chen YL. Stop using the misidentified cell line LO2 as a human hepatocyte. J Hepatol. 2024;80(5):e200\u20131. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.036. Epub 20231110.","journal-title":"J Hepatol"},{"issue":"5","key":"2031_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","volume":"44","author":"Y Lu","year":"2008","unstructured":"Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44(5):723\u201338. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2007.11.004. Epub 20071117.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2031_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.007. Epub 20130116.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"2031_CR30","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1083\/jcb.201706005","volume":"216","author":"E Zaganjor","year":"2017","unstructured":"Zaganjor E, Spinelli JB, Haigis MC. Strength in numbers: phosphofructokinase polymerization prevails in the liver. J Cell Biol. 2017;216(8):2239\u201341. Epub 20170717. doi: 10.1083\/jcb.201706005. PubMed PMID: 28716843; PubMed Central PMCID: PMC5551721.","journal-title":"J Cell Biol"},{"issue":"5","key":"2031_CR31","doi-asserted-by":"publisher","first-page":"e0286257","DOI":"10.1371\/journal.pone.0286257","volume":"18","author":"X Li","year":"2023","unstructured":"Li X, Lu Y, Liang X, et al. A new NASH model in aged mice with rapid progression of steatohepatitis and fibrosis. PLoS ONE. 2023;18(5):e0286257.","journal-title":"PLoS ONE"},{"issue":"4","key":"2031_CR32","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.26937","volume":"59","author":"VL Gadd","year":"2014","unstructured":"Gadd VL, Skoien R, Powell EE, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59(4):1393\u2013405.","journal-title":"Hepatology"},{"issue":"4","key":"2031_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","volume":"1","author":"J Bhattacharjee","year":"2017","unstructured":"Bhattacharjee J, Kirby M, Softic S, et al. Hepatic natural killer T-cell and CD8\u2009+\u2009T\u2010cell signatures in mice with nonalcoholic steatohepatitis. Hepatol Commun. 2017;1(4):299\u2013310.","journal-title":"Hepatol Commun"},{"key":"2031_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.07","volume":"154","author":"CP Woods","year":"2015","unstructured":"Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94\u2013103. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.07. Epub 20150801.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2031_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2147\/DMSO.S247379","volume":"13","author":"L Rahimi","year":"2020","unstructured":"Rahimi L, Rajpal A, Ismail-Beigi F. Glucocorticoid-Induced fatty liver disease. Diabetes Metab Syndr Obes. 2020;13:1133\u201345. Epub 20200416. doi: 10.2147\/dmso.S247379. PubMed PMID: 32368109; PubMed Central PMCID: PMC7171875.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2031_CR36","doi-asserted-by":"publisher","unstructured":"Gao J, Zhang H, Zhang F. Research progress of TIPE2 in immune-related diseases. Int Immunopharmacol. 2023;121:110514. Epub 20230620. https:\/\/doi.org\/10.1016\/j.intimp.2023.110514. PubMed PMID: 37348234.","DOI":"10.1016\/j.intimp.2023.110514"},{"issue":"38","key":"2031_CR37","doi-asserted-by":"publisher","first-page":"eabi6515","DOI":"10.1126\/sciadv.abi6515","volume":"7","author":"J Bi","year":"2021","unstructured":"Bi J, Cheng C, Zheng C, et al. TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity. Sci Adv. 2021;7(38):eabi6515. https:\/\/doi.org\/10.1126\/sciadv.abi6515. Epub 20210915.","journal-title":"Sci Adv"},{"issue":"39","key":"2031_CR38","doi-asserted-by":"publisher","first-page":"32546","DOI":"10.1074\/jbc.M112.348755","volume":"287","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wei X, Liu L, et al. TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem. 2012;287(39):32546\u201355. https:\/\/doi.org\/10.1074\/jbc.M112.348755. Epub 20120802.","journal-title":"J Biol Chem"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02031-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:54:29Z","timestamp":1767200069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2031"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02031-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"65"}}